PL2421879T3 - Nowe nukleozydy 7-deazapurynowe do zastosowań terapeutycznych - Google Patents
Nowe nukleozydy 7-deazapurynowe do zastosowań terapeutycznychInfo
- Publication number
- PL2421879T3 PL2421879T3 PL10734433T PL10734433T PL2421879T3 PL 2421879 T3 PL2421879 T3 PL 2421879T3 PL 10734433 T PL10734433 T PL 10734433T PL 10734433 T PL10734433 T PL 10734433T PL 2421879 T3 PL2421879 T3 PL 2421879T3
- Authority
- PL
- Poland
- Prior art keywords
- novel
- therapeutic uses
- deazapurine nucleosides
- deazapurine
- nucleosides
- Prior art date
Links
- 239000002777 nucleoside Substances 0.000 title 1
- 125000003835 nucleoside group Chemical group 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/14—Pyrrolo-pyrimidine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17165609P | 2009-04-22 | 2009-04-22 | |
| EP10734433.5A EP2421879B1 (en) | 2009-04-22 | 2010-04-19 | Novel 7-deazapurine nucleosides for therapeutic uses |
| PCT/CZ2010/000050 WO2010121576A2 (en) | 2009-04-22 | 2010-04-19 | Novel 7-deazapurine nucleosides for therapeutic uses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2421879T3 true PL2421879T3 (pl) | 2014-02-28 |
Family
ID=42768153
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10734433T PL2421879T3 (pl) | 2009-04-22 | 2010-04-19 | Nowe nukleozydy 7-deazapurynowe do zastosowań terapeutycznych |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US9321800B2 (https=) |
| EP (1) | EP2421879B1 (https=) |
| JP (2) | JP5721275B2 (https=) |
| CN (2) | CN102459300B (https=) |
| AU (3) | AU2010238985B2 (https=) |
| CA (2) | CA2966647A1 (https=) |
| DK (1) | DK2421879T3 (https=) |
| ES (1) | ES2437917T3 (https=) |
| HR (1) | HRP20131021T1 (https=) |
| MX (1) | MX2011011160A (https=) |
| NZ (2) | NZ700583A (https=) |
| PL (1) | PL2421879T3 (https=) |
| PT (1) | PT2421879E (https=) |
| SI (1) | SI2421879T1 (https=) |
| WO (1) | WO2010121576A2 (https=) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102459300B (zh) * | 2009-04-22 | 2014-12-10 | 捷克有机化学和生物化学研究院 | 用于治疗用途的新的7-脱氮嘌呤核苷 |
| AU2010330823A1 (en) * | 2009-12-18 | 2012-07-05 | Joslin Diabetes Center, Inc. | Beta-cell replication promoting compounds and methods of their use |
| CN102319254B (zh) * | 2011-07-20 | 2013-06-19 | 上海交通大学 | 5-碘代杀菌核素在制备抗肿瘤药物中的应用 |
| CZ305466B6 (cs) * | 2013-11-04 | 2015-10-14 | Ústav organické chemie a biochemie Akademie věd České republiky, v. v. i. | Substituované 7-deazapurinové ribonukleosidy pro terapeutické použití |
| ES2792036T3 (es) | 2014-11-14 | 2020-11-06 | Nerviano Medical Sciences Srl | Derivados de 6-amino-7-biciclo-7-deaza-purina como inhibidores de cinasa |
| CN109790143A (zh) | 2016-05-10 | 2019-05-21 | C4医药公司 | 用于靶蛋白降解的胺连接的c3-戊二酰亚胺降解决定子体 |
| EP4491236A3 (en) | 2016-05-10 | 2025-04-02 | C4 Therapeutics, Inc. | Heterocyclic degronimers for target protein degradation |
| EP3454862B1 (en) | 2016-05-10 | 2024-09-11 | C4 Therapeutics, Inc. | Spirocyclic degronimers for target protein degradation |
| CN109641874A (zh) | 2016-05-10 | 2019-04-16 | C4医药公司 | 用于靶蛋白降解的c3-碳连接的戊二酰亚胺降解决定子体 |
| CA3029170C (en) | 2016-06-29 | 2021-02-16 | Ustav Organicke Chemie A Biochemie Av Cr, V.V.I. | Substituted thienopyrrolopyrimidine ribonucleosides for therapeutic use |
| CZ307334B6 (cs) | 2016-08-02 | 2018-06-13 | Ăšstav organickĂ© chemie a biochemie AV ÄŚR, v.v.i. | Substituované heteropentadieno-pyrrolopyrimidinové ribonukleosidy pro terapeutické použití |
| US11168090B2 (en) | 2017-01-18 | 2021-11-09 | Array Biopharma Inc. | Substituted pyrazolo[1,5-a]pyrazines as RET kinase inhibitors |
| EP4717317A2 (en) | 2017-06-20 | 2026-04-01 | C4 Therapeutics, Inc. | N/o-linked degrons and degronimers for protein degradation |
| US11072628B2 (en) | 2017-10-19 | 2021-07-27 | Universiteit Gent | Nucleoside analogues for the treatment of parasitic infections |
| WO2019143991A1 (en) * | 2018-01-18 | 2019-07-25 | Array Biopharma Inc. | SUBSTITUTED PYRAZOLO[3,4-d]PYRIMIDINE COMPOUNDS AS RET KINASE INHIBITORS |
| CN111615514B (zh) | 2018-01-18 | 2022-10-11 | 奥瑞生物药品公司 | 作为ret激酶抑制剂的取代的吡唑并[4,3-c]吡啶化合物 |
| EP3740491A1 (en) | 2018-01-18 | 2020-11-25 | Array Biopharma, Inc. | Substituted pyrrolo[2,3-d]pyrimidines compounds as ret kinase inhibitors |
| CZ308104B6 (cs) | 2018-03-12 | 2020-01-08 | Ăšstav organickĂ© chemie a biochemie AV ÄŚR, v. v. i. | Pyridinopyrrolopyrimidinové ribonukleosidy pro terapeutické použití |
| WO2020033288A1 (en) * | 2018-08-07 | 2020-02-13 | Merck Sharp & Dohme Corp. | Prmt5 inhibitors |
| EP3849986B1 (en) | 2018-09-10 | 2022-06-08 | Array Biopharma, Inc. | Fused heterocyclic compounds as ret kinase inhibitors |
| MX2021015772A (es) * | 2019-06-18 | 2022-01-31 | Taiho Pharmaceutical Co Ltd | Compuesto de carbonato novedoso que tiene esqueleto de pirrolopirimidina o sal farmaceuticamente aceptable del mismo. |
| WO2021164848A1 (en) * | 2020-02-17 | 2021-08-26 | Katholieke Universiteit Leuven | Novel 6-substituted 7-deazapurines and corresponding nucleosides as medicaments |
| KR102639275B1 (ko) * | 2021-06-08 | 2024-02-21 | 퓨쳐메디신 주식회사 | 다중 표적 인산화효소 저해 활성을 갖는 뉴클레오사이드 유도체 및 이를 포함하는 암의 예방 및 치료용 약학적 조성물 |
| WO2023052468A1 (en) | 2021-09-28 | 2023-04-06 | Universiteit Antwerpen | Nucleoside analogues for the treatment of parasitic infections |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL108523A0 (en) * | 1993-02-03 | 1994-05-30 | Gensia Inc | Pharmaceutical compositions containing adenosine kinase inhibitors for preventing or treating conditions involving inflammatory responses and pain |
| WO2002057425A2 (en) * | 2001-01-22 | 2002-07-25 | Merck & Co., Inc. | Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| AU2002353165A1 (en) * | 2001-12-17 | 2003-06-30 | Ribapharm Inc. | Deazapurine nucleoside libraries and compounds |
| AU2003232071A1 (en) * | 2002-05-06 | 2003-11-17 | Genelabs Technologies, Inc. | Nucleoside derivatives for treating hepatitis c virus infection |
| US20040157892A1 (en) | 2003-02-12 | 2004-08-12 | Crompton Co./Cie | Pesticidal fluoroethyl pyrazoles |
| JP2007509939A (ja) * | 2003-10-27 | 2007-04-19 | ジェネラブズ テクノロジーズ インコーポレーティッド | ウイルス感染を治療するためのヌクレオシド化合物 |
| US7202223B2 (en) * | 2003-10-27 | 2007-04-10 | Genelabs Technologies, Inc. | Nucleoside compounds for treating viral infections |
| EP1682564A1 (en) * | 2003-10-27 | 2006-07-26 | Genelabs Technologies, Inc. | METHODS FOR PREPARING 7-(2 -SUBSTITUTED-s-D-RIBOFURANO SYL)-4-(NR2R3)-5-(SUBSTITUTED ETHYN-1-YL)-PYRROLO 2,3-D|PYRIMIDINE DERIVATIVES |
| EP1781101A2 (en) * | 2004-07-29 | 2007-05-09 | Metabasis Therapeutics, Inc. | Novel nucleoside derivatives |
| CN101977923B (zh) * | 2008-01-18 | 2014-10-08 | 捷克有机化学和生物化学研究院 | 抑制细胞生长的7-脱氮嘌呤核苷 |
| NZ590005A (en) * | 2008-06-23 | 2012-06-29 | Janssen Pharmaceutica Nv | Piperidyl acrylamide antogonists of ccr2 |
| GB0815968D0 (en) * | 2008-09-03 | 2008-10-08 | Angeletti P Ist Richerche Bio | Antiviral agents |
| CN102459300B (zh) * | 2009-04-22 | 2014-12-10 | 捷克有机化学和生物化学研究院 | 用于治疗用途的新的7-脱氮嘌呤核苷 |
-
2010
- 2010-04-19 CN CN201080027802.1A patent/CN102459300B/zh active Active
- 2010-04-19 MX MX2011011160A patent/MX2011011160A/es active IP Right Grant
- 2010-04-19 EP EP10734433.5A patent/EP2421879B1/en active Active
- 2010-04-19 WO PCT/CZ2010/000050 patent/WO2010121576A2/en not_active Ceased
- 2010-04-19 ES ES10734433.5T patent/ES2437917T3/es active Active
- 2010-04-19 NZ NZ700583A patent/NZ700583A/en active IP Right Revival
- 2010-04-19 JP JP2012506333A patent/JP5721275B2/ja active Active
- 2010-04-19 NZ NZ596301A patent/NZ596301A/en unknown
- 2010-04-19 PT PT107344335T patent/PT2421879E/pt unknown
- 2010-04-19 CA CA2966647A patent/CA2966647A1/en not_active Abandoned
- 2010-04-19 HR HRP20131021AT patent/HRP20131021T1/hr unknown
- 2010-04-19 CA CA2759131A patent/CA2759131C/en active Active
- 2010-04-19 SI SI201030450T patent/SI2421879T1/sl unknown
- 2010-04-19 US US14/394,262 patent/US9321800B2/en active Active
- 2010-04-19 CN CN201410643709.3A patent/CN104497084B/zh active Active
- 2010-04-19 DK DK10734433.5T patent/DK2421879T3/da active
- 2010-04-19 PL PL10734433T patent/PL2421879T3/pl unknown
- 2010-04-19 AU AU2010238985A patent/AU2010238985B2/en active Active
-
2014
- 2014-10-20 JP JP2014213410A patent/JP6087889B2/ja active Active
-
2015
- 2015-07-22 AU AU2015205885A patent/AU2015205885B2/en active Active
-
2016
- 2016-03-17 US US15/073,502 patent/US9624257B2/en active Active
-
2017
- 2017-03-08 US US15/453,702 patent/US10294262B2/en active Active
- 2017-06-19 AU AU2017204148A patent/AU2017204148B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2421879T3 (pl) | Nowe nukleozydy 7-deazapurynowe do zastosowań terapeutycznych | |
| AP3076A (en) | Carba-nucleoside analogs for antiviral treatment | |
| AP2922A (en) | Carbra-nucleoside analogs for antiviral treatment | |
| HRP20171759T8 (hr) | Antiviralni spojevi | |
| LT2231689T (lt) | Nauji citostatiniai 7-deazapurino nukleozidai | |
| IL210855A0 (en) | Novel adenine derivatives | |
| ZA201104638B (en) | Nucleoside analogs | |
| IL219965A0 (en) | Novel antiviral compounds | |
| IL207826A0 (en) | Antiviral therapeutic agents | |
| IL208351A0 (en) | Antiviral therapy | |
| GB0905485D0 (en) | Antiviral therapy | |
| GB0906026D0 (en) | Therapeutic compounds | |
| GB0908952D0 (en) | Antiviral therapy | |
| GB0819857D0 (en) | Antiviral therapy | |
| GB0916308D0 (en) | Therapeutic compounds | |
| GB0916608D0 (en) | Therapeutic compounds | |
| GB0911266D0 (en) | Therapeutic compounds | |
| GB0900712D0 (en) | Therapeutic compounds | |
| GB0717955D0 (en) | Preparation of modified nucleosides | |
| ZA201203613B (en) | Novel antiviral compounds | |
| GB0922520D0 (en) | Novel antiviral compounds | |
| GB0906209D0 (en) | Antiviral compounds | |
| GB0908677D0 (en) | Antiviral compounds | |
| GB0914473D0 (en) | Antiviral compounds |